Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Lloydspharmacy backs GMC plan to shore up online prescribing rules

Proposals to tighten up online prescribing services such as those offered by some pharmacy websites have been backed by Lloydspharmacy.

Lloydspharmacy welcomed the General Medical Council's (GMC) proposals to make it compulsory for online doctors to liaise with patients' GPs, saying it would make it harder for doctors to break guidelines. The GMC said online doctors should ask patient permission to contact their GP before starting treatment and communicate any subsequent information to the doctors.

The GMC also warned online doctors not to discourage patients from sharing information, particularly "if you have a commercial of financial interest in providing care or if you think your patient's general practitioner will discourage them from accepting your treatment".

Tom Brett of Lloydspharmacy's Online Doctor service said he was in favour of a "more prescriptive approach" to online prescribing.

 "Our online doctor service makes clear to patients the importance of informing their GP and we encourage them to ask us to do this on their behalf," Dr Brett told C+D.

However, Dr Brett warned that the proposals should not infringe on patient control, adding: "It is important that the control of such information remains with the patient, who should be able to choose what information is routinely conveyed to their GP."

A consultation on the GMC proposals will run until May 27. To take part go here.

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD013926

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel